Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for indigenous and non-indigenous people with cancer in Australia

Table 6 Average expenditure and adjusted cost ratio of Medicare service types by Indigenous status

BTOS name	BTOS code	Mean (SD) co-payment		Adjusted Cost Ratio^#
BTOS name	BTOS code	Indigenous	Non-indigenous	Adjusted Cost Ratio^#
Non-referred attendances – GP/VRGP	101	73.4 (197)	162.6 (286)	0.42***
Non-referred attendances – enhanced primary care	102	0.05 (0.9)	2 (19.2)	0.009***
Non-referred attendances – other	103	22.8 (126.9)	46.9 (120.8)	0.50*
Non-referred attendances – practice nurse items	110	0.09 (1.1)	0.2 (2)	0.11
Other allied health	150	19.9 (93.9)	58.9 (183.8)	0.33**
Specialist attendances	200	260.3 (670.6)	978.3 (1650.2)	0.25***
Anaesthetics	400	580.9 (658.6)	1005.5 (1097.5)	0.54***
Pathology collection items	501	10.8 (48.1)	42.1 (128.2)	0.23***
Pathology tests	502	109.5 (440.5)	481.1 (1215.2)	0.21***
Diagnostic imaging	600	112.9 (329)	400.4 (768.6)	0.26***
Operations	700	671.3 (1463.7)	1797.9 (2510.7)	0.39***
Assistance at operations	800	366.8 (303.3)	392.1 (345.1)	0.83
Optometry	900	0.6 (4.9)	0.9 (5.7)	2.24
Other MBS Services	1000	159.4 (702.7)	682.7 (1487.2)	0.14***
Radiotherapy and therapeutic nuclear medicine	1100	85.8 (495.3)	375.8 (1233.9)	0.26***
All BTOS combined		1191 (3099)	4639 (6891)	0.25***

^#Adjusted for age at diagnosis, sex, rurality, area-based deprivation quintile, and broad cancer site groupings
*significant at 0.05 level
**significant at 0.01 level
***significant at 0.001 level

ISSN: 1475-9276